Kathleen is committed to education, evidence-based practices, and advocacy in the field of substance use with decades of leadership experience. As the founder of Moms for All Paths to Recovery, she is a fierce advocate for expanding access to diverse and effective treatment. She is deeply committed to advancing the foundation’s mission to create equitable access to ibogaine.

Kathleen’s professional background includes an illustrious career in hospitality, having managed high-end luxury hotels and resorts across the nation, including 24 years with Loews Hotels and serving as the Managing Director of The Plaza Hotel in New York City. She is currently the Alisal Guest Ranch Resort & Spa General Manager in California’s Santa Ynez Valley, where her focus on community and connection underscores her leadership style.

A peer coach with the Partnership to End Addiction and fully trained in the Invitation to Change Approach (ITC) through the Center for Motivation and Change, Kathleen blends her lived experience with her daughter’s decades of substance use with a commitment to evidence-based practices. Her story and advocacy were recently featured in the documentary Untreated & Unheard, highlighting her dedication to amplifying the voices of families affected by substance use.

As President, Kathleen leads with compassion and vision, working to ensure Vilomah’s efforts honor those lost to preventable deaths of despair while fostering healing and building a more just and equitable society.

Susan is a fearless advocate and visionary thinker committed to transforming mental health and substance use treatment while addressing the systemic failures that perpetuate preventable deaths of despair. For six years, she navigated stigma, misinformation, and a deeply flawed healthcare system in her relentless effort to help her son Tyler access effective treatment for his opioid addiction. After losing Tyler in October 2020, Susan embraced the belief that such losses are a universal call to action—channeling the powerful forces of grief and love to demand systemic change and foster a more compassionate, connected society. Grounded in a deep commitment to integrity and transparency, Susan approaches her work with humility, a willingness to learn, and an unrelenting determination to improve the system. She believes that meaningful solutions emerge through listening, collaboration, and the courage to challenge entrenched norms. Her efforts are driven by a dedication to dismantling stigma, advancing innovative therapies, empowering others, and ensuring equitable access to care. Through extensive research into ibogaine and other plant medicines, Susan has developed a deep conviction in their potential to address the root causes of problematic substance use. She is committed to ensuring these groundbreaking therapies remain in the public domain—accessible to all who need them—and integrating them into patient-focused, individualized care models that promote healing, dignity, and empowerment. With a professional background in publishing and communication, Susan uses her skills and lived experience to advocate for meaningful policy reforms. Her ultimate goal is to transform the substance use and mental health treatment landscape into one that addresses underlying causes, and promotes self-actualization for individuals and communities alike.

Nicole is a dedicated advocate for creating compassionate, evidence-based solutions for substance use disorder and improving outcomes for all vulnerable populations. As a mother, Nicole is deeply committed to building a gentler path for future generations, inspired by her vision of a more equitable and supportive system of care. Professionally, Nicole brings extensive expertise in healthcare finance and regulatory navigation. Her career includes serving as a comptroller for a specialty healthcare finance group and as the president of a company specializing in medical fraud, waste, and abuse prevention and remediation. Nicole is also an expert in navigating federal regulatory frameworks, particularly those governing DEA Schedule I research, a critical area for advancing studies on innovative treatments for substance use disorder and mental health. Nicole’s unique blend of professional financial experience and personal passion drives her efforts to contribute meaningfully to the movement for systemic change, ensuring better access to care, equity, and dignity for those in need.

Sandra is a passionate advocate for drug policy reform, driven by her personal experience navigating the healthcare system on behalf of her late son, Jeffrey. During her career in sub-acute healthcare, Sandra honed her skills as an effective patient advocate. However, she was unprepared for the barriers created by stigma when advocating for Jeffrey’s medical and mental health treatment. Prescribed opioids for an injury at just 15 years old, Jeffrey’s journey highlighted numerous systemic failures—from inadequate support in methadone clinics to cardiologists who denied him the surgery that could have saved his life. Tragically, Jeffrey passed away at the age of 24 in 2012. Since Jeffrey’s death, Sandra has become a dedicated voice in the fight for change. She has organized local events for International Overdose Awareness Day, participated in national rallies, and shared Jeffrey’s heartbreaking story to raise awareness and push for drug policy reform. Her advocacy spans her home state of California and Washington, D.C., with a long-term goal of establishing a Ryan White-type program for intravenous drug use (IVDU)-related endocarditis—a critical yet overlooked issue within the broader addiction crisis. Sandra’s work is rooted in honoring Jeffrey’s memory and ensuring that others facing similar struggles receive the compassionate care and systemic support they deserve.